EGFR Positive Non Small Cell Lung Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Active, not recruiting
  • Advanced Solid Tumors
  • +4 more
  • Phoenix, Arizona
  • +15 more
2022-04-04
Apr 4, 2022
N
A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)
Active, not recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Goyang-Si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
2022-04-04
Apr 4, 2022
A
A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients
Recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
  • +3 more
2021-10-27
Oct 27, 2021
N
Phase 2 Study of Dacomitinib in NSCLC
Recruiting
  • NSCLC Stage IIIB
  • +4 more
  • Hong Kong, Hong Kong
  • +8 more
2021-09-20
Sep 20, 2021
N
Osimertinib for Advanced EGFR-positive NSCLC Patients
Recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Non Small Cell Lung Cancer
    • Singapore, Singapore
      National University Hospital
    2021-08-31
    Aug 31, 2021
    K
    Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients
    Active, not recruiting
    • EGFR Positive Non-small Cell Lung Cancer
    • Anyang, Gyeonggi-do, Korea, Republic of
    • +7 more
    2021-07-13
    Jul 13, 2021
    M
    Patient-centered, Optimal Integration of Survivorship and Palliative Care
    Not yet recruiting
    • Stage IV Non-small Cell Lung Cancer
    • +7 more
    • POISE
    • Boston, Massachusetts
      Massachusetts General Hospital
    2021-05-20
    May 20, 2021
    F
    A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases
    Not yet recruiting
    • EGFR Positive Non-small Cell Lung Cancer
    • Brain Metastases
    • Hangzhou, Zhejiang, China
      Hangzhou Cancer Hospital
    2020-11-19
    Nov 19, 2020
    T
    Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC
    Unknown status
    • EGFR Positive Non-small Cell Lung Cancer
      • Heidelberg, Germany
        Thoraxklinik-Heidelberg gGmbH - Universitätsklinikum Heidelberg
      2020-03-09
      Mar 9, 2020
      B
      Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma
      Unknown status
      • EGFR Positive Non-small Cell Lung Cancer
      • Adenocarcinoma
      • Beijing, Beijing, China
      • +10 more
      2018-07-12
      Jul 12, 2018
      B
      Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
      Unknown status
      • EGFR Positive Non-small Cell Lung Cancer
      • Adenocarcinoma
      • Beijing, Beijing, China
        Chinese People's Liberation Army (PLA) General Hospital
      2017-02-07
      Feb 7, 2017
      F
      A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy
      Not yet recruiting
      • Lung Adenocarcinoma
      • EGFR Positive Non-small Cell Lung Cancer
      • EGFR-TKI
      • Thoracic Hypofractionated Radiotherapy
      • (no location specified)
      2016-05-26
      May 26, 2016
      B
      Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
      Unknown status
      • EGFR Positive Non-small Cell Lung Cancer
      • Adenocarcinoma
      • Sequential Icotinib Plus Chemotherapy
      • Icotinib
      • Lanzhou, Gansu, China
      • +30 more
      2015-04-27
      Apr 27, 2015
      B
      Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
      Unknown status
      • EGFR Positive Non-small Cell Lung Cancer
      • Adenocarcinoma
      • Sequential and maintenance icotinib
      • Maintenance icotinib
      • NanNing, Guangxi, China
        First Affiliated Hospital of Guangxi Medical University
      2014-07-17
      Jul 17, 2014